Planning the New Normal
May 13, 2020
“During these difficult and unforeseen times, it is vital that we take action when it comes to planning for the ‘New Normal’. When restrictions are partially lifted, our aim as a translational research community will be to provide momentum for innovation for the future.
What should be done first? How does one restart a translational research agenda? How does one maneuver within the new system? Which priorities; data collection, grant writing, journal publishing, should come first? What are the implications for trials, licencing, approvals in this ‘New Normal’?
Join key opinion leaders as we brainstorm and discuss strategies to start unravelling what will need to be done to find a new balance.”
COVID Contact Tracing: Opening Pandora’s box
June 3, 2020
The COVID-19 pandemic is a deadly crisis and, an opportunity for rapid technological and social change. Contact Tracing, a longstanding public health strategy for managing the spread of infections is a prime area for innovation. Contact tracing works by trying to identify everyone whom a sick person may have exposed. Then reaching out to potentially exposed people to help them take appropriate action.
To date, this has been a labour-intensive manual process, but the potential and prevalence of mobile for proximity and location tracking present a new and tempting Pandora’s box for epidemiological surveillance. Selectively delivering individualized alerts about potential exposure may be a significant tool for managing current and future outbreaks, informing health policy and expediting recovery.
But while there may be initial public health benefits, there may also be significant long-term risks and unintended consequences of their deployment.
Join us for a discussion of “Contact Tracing Apps”: How do they work? What are the trade-offs? Can we reap the benefits and minimize risks by building in Privacy by Design?
How has COVID changed Translation?
September 8, 2020
COVID-19 has disrupted the world. We are changing almost every aspect of our lives from the way we walk down the street to the way we socialize, shop, study, and work. The challenges of this pandemic also provide opportunities for science led decision-making to innovate policy, regulation, ethics, intellectual property, and funding opportunities.
Join TR Talks as we discuss how science-driven translational of research can help us establish evidence-based responses, policies, and innovations d after a pandemic.
Ethics & Patients in Research
October 6, 2020
A defining characteristic of translational research is collaboration, an important aspect of health science innovation. When trying to improve people’s health, we need to work with the peoples’ whose health we’re trying to improve. Although this seems self-evident and simple, it is not done as often as it should. How do we do better? Join TR talks this week as we discuss the nature of effective collaboration with patients, in translational research and the barriers to making it a reality.